# QUANTRX BIOMEDICAL CORP — Form D

QUANTRX BIOMEDICAL CORP of DOYLESTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2009-08-14. The offering totals $406.0M, of which $406.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2009-08-14
- Form: D
- Accession: 0001144204-09-043755
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $406.0M
- Amount sold: $406.0M
- Investors: 13
- Date of first sale: 2009-07-30
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-82060-8S

## Issuer

- Name: QUANTRX BIOMEDICAL CORP
- CIK: 0000820608
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 100 SOUTH MAIN STREET, DOYLESTOWN, PA, 18901
- Phone: 267-880-1595

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| William H Fleming | Director | Doylestown, PA |
| Sasha Afanassiev | Executive Officer | Doylestown, PA |
| William H Fleming | Executive Officer | Doylestown, PA |

## More

- [CIK 820608 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=820608&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001144204-09-043755.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.